The utilization of endovascular treatment for ruptured intracranial aneurysms is expected to change since the publication of the International Subarachnoid Aneurysm Trial (ISAT) in 2002. The authors performed this analysis to determine the impact of ISAT results on treatment selection for ruptured intracranial aneurysms and associated in-hospital outcomes using nationally representative data.
We determined the national estimates of treatments used for ruptured intracranial aneurysms and associated in-hospital outcomes, length of stay, mortality, and cost incurred using the Nationwide Inpatient Survey (NIS) data. The NIS is the largest all-payer inpatient care database in the US and contains data from 986 hospitals approximating a 20% stratified sample of US hospitals. All the variables pertaining to hospitalization were compared between 2000–2002 and 2004–2006, and in-hospital outcomes were analyzed using multivariate analysis.
In the 3-year periods prior to and after the ISAT, there were 70,637 and 77,352 admissions for ruptured intracranial aneurysms, respectively. There was a significant increase in endovascular treatment after publication of the ISAT (trend test, p < 0.0001) The in-hospital mortality for ruptured intracranial aneurysm admissions decreased from 27% to 24% (odds ratio [OR] 0.89, 95% CI 0.83–0.96, p = 0.003) after the publication of the ISAT. The cost of hospitalization after adjusting for procedures practices was not significantly higher after the publication of the ISAT ($21,437 vs $22,817, p < 0.89), but cost of hospitalization was higher in the post-ISAT period for patients undergoing endovascular procedure.
The results of the ISAT have been associated with a prominent change in practice patterns related to the treatment of ruptured aneurysms. The cost of hospitalization has increased and the mortality has decreased, presumably due to a larger proportion of patients receiving any treatment and endovascular treatment.
Abbreviations used in this paper: HCUP = Healthcare Cost and Utilization Project; ICD-9-CM = International Classification of Disease, 9th Revision, Clinical Modification; ISAT = International Subarachnoid Aneurysm Trial; LOS = length of stay; NIS = Nationwide Inpatient Survey; SAH = subarachnoid hemorrhage.
DerdeynCPBarrJDBerensteinAConnorsJJDionJEDuckwilerGR: The International Subarachnoid Aneurysm Trial (ISAT): a position statement from the Executive Committee of the American Society of Interventional and Therapeutic Neuroradiology and the American Society of Neuroradiology. AJNR Am J Neuroradiol24:1404–14082003
GnanalinghamKKApostolopoulosVBaraziSO'NeillK: The impact of the international subarachnoid aneurysm trial (ISAT) on the management of aneurysmal subarachnoid haemorrhage in a neurosurgical unit in the UK. Clin Neurol Neurosurg108:117–1232006
HohBLRabinovJDPryorJCCarterBSBarkerFGII: In-hospital morbidity and mortality after endovascular treatment of unruptured intracranial aneurysms in the United States, 1996–2000: effect of hospital and physician volume. AJNR Am J Neuroradiol24:1409–14202003
IkawaFOhbayashiNImadaYMatsushigeTKajiharaYInagawaT: Analysis of subarachnoid hemorrhage according to the Japanese Standard Stroke Registry Study—incidence, outcome, and comparison with the International Subarachnoid Aneurysm Trial. Neurol Med Chir (Tokyo)44:275–2762004
LanzinoGFraserKKanaanYWagenbachA: Treatment of ruptured intracranial aneurysms since the International Subarachnoid Aneurysm Trial: practice utilizing clip ligation and coil embolization as individual or complementary therapies. J Neurosurg104:344–3492006
MaudALakshminarayanKSuriMFVazquezGLanzinoGQureshiAI: Cost-effectiveness analysis of endovascular versus neurosurgical treatment for ruptured intracranial aneurysms in the United States. J Neurosurg110:880–8862009
McPheeJTSchanzerAMessinaLMEslamiMH: Carotid artery stenting has increased rates of postprocedure stroke, death, and resource utilization than does carotid endarterectomy in the United States, 2005. J Vasc Surg48:1442–14502008
MolyneuxAKerrRStrattonISandercockPClarkeMShrimptonJ: International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet360:1267–12742002
National Institutes for Clinical Excellence: Coil embolization of ruptured intracranial aneurysmsNational Health ServiceLondon UK(http://www.nice.org.uk:80/nicemedia/live/11036/30674/30674.pdf) [Accessed June 22 2010]
QureshiAIHutsonADHarbaughREStiegPEHopkinsLN: North American Trial of Unruptured and Ruptured Aneurysms Planning Committee: Methods and design considerations for randomized clinical trials evaluating surgical or endovascular treatments for cerebrovascular diseases. Neurosurgery54:248–2672004
RaabeASchmiedekPSeifertVStolkeD: German Society of Neurosurgery Section on Vascular Neurosurgery: Position Statement on the International Subarachnoid Hemorrhage Trial (ISAT). Zentralbl Neurochir64:99–1032003
RosamondWDFolsomARChamblessLEWangCHMcGovernPGHowardG: Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke30:736–7431999